A kalihinol analog disrupts apicoplast function and vesicular trafficking in <i>P. falciparum</i> malaria. [PDF]
Chahine Z +28 more
europepmc +1 more source
Safeguarding artemisinin: integrating bioproduction innovation and resistance management for malaria eradication. [PDF]
Farmanpour Kalalagh K +7 more
europepmc +1 more source
Fast-Acting Chalcogen-Phosphoranes Inhibit Sensitive and Resistant <i>Plasmodium falciparum</i> Strains. [PDF]
Moura IMR +6 more
europepmc +1 more source
Chemical modulation of chloroplast de- and redifferentiation reveals a role for the SAL1-PAP retrograde pathway in facilitating plastid transitions. [PDF]
Perez-Colao P +7 more
europepmc +1 more source
Promiscuity of an Alcohol-Dependent Hemiterpene Pathway for the In Vivo Production of a Non-Natural Alkylated Tryptophan Derivative. [PDF]
Gayen AK +3 more
europepmc +1 more source
Fosmidomycin is a natural antibiotic with potent IspC (DXR, 1-deoxy-d-xylulose-5-phosphate reductoisomerase) inhibitory activity. This enzyme catalyzes the first committed step of the non-mevalonate isoprenoid biosynthesis pathway, which is essential in most bacteria, including A. baumanii and M.
Serge Van Calenbergh +2 more
exaly +5 more sources
Related searches:
Fosmidomycin as an Antimalarial Drug: A Meta-Analysis of Clinical Trials
Future Microbiology, 2015With first indications of resistance against artemisinin compounds, the development of novel alternative antimalarials remains an urgent need. One candidate is fosmidomycin (Fos), a phosphonic acid derivative. This PRISMA guideline-adhering and PROSPERO-registered systematic review and meta-analysis provides an overview of the state-of-the-art of the ...
Benjamin Mordmüller +2 more
exaly +4 more sources
Fosmidomycin for the treatment of malaria
Parasitology Research, 2003In malaria parasites, isoprenoids are synthesised by the mevalonate independent 1-deoxy- D-xylulose 5-phosphate (DOXP) pathway. Fosmidomycin, a natural antibiotic originally developed for the treatment of bacterial infections, represents an inhibitor of DOXP reductoisomerase, an essential enzyme of this pathway.
Jochen, Wiesner +2 more
openaire +2 more sources
Prodrugs of Reverse Fosmidomycin Analogues
Journal of Medicinal Chemistry, 2015Fosmidomycin inhibits IspC (Dxr, 1-deoxy-d-xylulose 5-phosphate reductoisomerase), a key enzyme in nonmevalonate isoprenoid biosynthesis that is essential in Plasmodium falciparum. The drug has been used successfully to treat malaria patients in clinical studies, thus validating IspC as an antimalarial target.
Brücher, Karin +12 more
openaire +4 more sources
Carboxylic Acid Analogues of Fosmidomycin
Zeitschrift für Naturforschung B, 2003N-Alkylation of N-Boc-O-benzylhydroxylamine (1) with benzyl 4-bromobutyrate (2) in DMF gave N,O-bisprotected benzyl 4-hydroxyamino-butyrate (3), which was converted into 4-benzyloxyamino-butyric acid benzyl ester (4) with TFA in methylene chloride.
Thomas Kurz +2 more
openaire +1 more source

